Prevalence of N-Methyl-d-Aspartate Receptor antibody (NMDAR-Ab) encephalitis in patients with first episode psychosis and treatment resistant schizophrenia on clozapine, a population based study
- 1 June 2020
- journal article
- research article
- Published by Elsevier BV in Schizophrenia Research
- Vol. 222, 455-461
- https://doi.org/10.1016/j.schres.2019.11.023
Abstract
No abstract availableFunding Information
- Trinity College Dublin.
This publication has 41 references indexed in Scilit:
- Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood–brain barrier integrityMolecular Psychiatry, 2013
- Prevalence of autoimmune diseases in in-patients with schizophrenia: nationwide population-based studyThe British Journal of Psychiatry, 2012
- Disrupted surface cross-talk between NMDA and Ephrin-B2 receptors in anti-NMDA encephalitisBrain, 2012
- Cognitive deficits following anti-NMDA receptor encephalitisJournal of Neurology, Neurosurgery & Psychiatry, 2011
- Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitisThe Lancet Neurology, 2011
- Disease-relevant autoantibodies in first episode schizophreniaZeitschrift für Neurologie, 2010
- N-methyl-d-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexesBrain, 2010
- Review of the operational definition for first‐episode psychosisEarly Intervention in Psychiatry, 2009
- Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodiesThe Lancet Neurology, 2008
- Paraneoplastic anti–N‐methyl‐D‐aspartate receptor encephalitis associated with ovarian teratomaAnnals of Neurology, 2007